| Application no. and date | 20834024.0 (espacenet) (Federated) (European Patent Register), 20201204 | | Patent/reg. no. and date | DK/EP 3886991, 20220921 | | Publication date | 20211006 | | Priority no. and date | US 201962946586 P, 20191211 | | EP pub. no. and date |
EP 3886991 20211006 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V448155DK00 | | Inventor | SI, Chong, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
GUO, Deqi, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
BOULET, Serge Louis, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
FORTNER, Kevin Charles, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
HYMAN, David Michael, c/o Eli Lilly And Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
PENG, Sheng-Bin, c/o Eli Lillly And Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/553 (2006.01) , A61P 35/00 (2006.01) , C07D 487/04 (2006.01) , C07D 498/04 (2006.01) | | Title | KRas G12C-inhibitorer | | Int. application no. | US2020063272 | | Int. publication no. | WO2021118877 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
